Compact CRISPR system enables portable COVID-19 testing
A new form of CRISPR technology that takes advantage of a compact RNA-editing protein could lead to improved diagnostic tests for COVID-19.
Nov 29, 2021
0
64
ACS Synthetic Biology is a monthly peer-reviewed journal dedicated to research in synthetic biology and biological systems. Led by Editor-in-Chief Christopher A. Voigt of the Massachusetts Institute of Technology, the journal publishes high-quality research that demonstrate integrative, molecular approaches enabling better understanding of the organization and function of cells, tissues, and organisms in systems.
A new form of CRISPR technology that takes advantage of a compact RNA-editing protein could lead to improved diagnostic tests for COVID-19.
Nov 29, 2021
0
64
Bioengineers at the University of California San Diego are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells ...
Oct 15, 2019
0
8
Researchers at the University of Southampton have engineered cells with a 'built-in genetic circuit' that produces a molecule that inhibits the ability of tumours to survive and grow in their low oxygen environment.
Nov 24, 2016
0
110
A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other sites of disease.
Apr 17, 2014
0
0